Published in J Biol Chem on August 23, 1996
Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res (2008) 5.29
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci (2012) 4.92
Structure-neurotoxicity relationships of amyloid beta-protein oligomers. Proc Natl Acad Sci U S A (2009) 3.06
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One (2010) 2.78
Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med (2012) 2.77
Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta. Proc Natl Acad Sci U S A (2003) 2.33
In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation. Proc Natl Acad Sci U S A (1999) 2.24
Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? Diabetologia (2010) 2.21
A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. Biophys J (2001) 1.96
Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils. J Neurosci (2010) 1.92
Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis. Am J Pathol (2006) 1.73
Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils. PLoS Comput Biol (2007) 1.71
Molecular dynamics simulation of amyloid beta dimer formation. Biophys J (2004) 1.63
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement (2009) 1.49
2D IR provides evidence for mobile water molecules in beta-amyloid fibrils. Proc Natl Acad Sci U S A (2009) 1.49
The molecular basis of functional bacterial amyloid polymerization and nucleation. J Biol Chem (2008) 1.47
Ultrastructural organization of amyloid fibrils by atomic force microscopy. Biophys J (2000) 1.46
Amyloids: friend or foe? J Alzheimers Dis (2008) 1.46
Alzheimer's disease: synapses gone cold. Mol Neurodegener (2011) 1.43
Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research. Nat Protoc (2010) 1.40
Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption. Biophys J (2001) 1.37
Alzheimer's disease and the amyloid-beta peptide. J Alzheimers Dis (2010) 1.33
Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia. J Neuroinflammation (2009) 1.32
The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br J Pharmacol (2005) 1.32
Preparing synthetic Aβ in different aggregation states. Methods Mol Biol (2011) 1.26
Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders. Curr Alzheimer Res (2008) 1.26
Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide. Biochem J (2000) 1.23
Amyloid-β as a modulator of synaptic plasticity. J Alzheimers Dis (2010) 1.22
Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease. Am J Pathol (1998) 1.21
Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. J Biol Inorg Chem (2004) 1.21
A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade. Proc Natl Acad Sci U S A (2004) 1.18
Appearance of sodium dodecyl sulfate-stable amyloid beta-protein (Abeta) dimer in the cortex during aging. Am J Pathol (1999) 1.17
Small molecule microarrays enable the discovery of compounds that bind the Alzheimer's Aβ peptide and reduce its cytotoxicity. J Am Chem Soc (2010) 1.15
Amyloid precursor protein transgenic mouse models and Alzheimer's disease: understanding the paradigms, limitations, and contributions. Alzheimers Dement (2009) 1.13
PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42. J Neurochem (2006) 1.12
Extracellular phosphorylation of the amyloid β-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease. EMBO J (2011) 1.10
The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation? Alzheimers Res Ther (2010) 1.09
Oligomerization of beta-amyloid of the Alzheimer's and the Dutch-cerebral-haemorrhage types. Biochem J (2000) 1.05
Sedimentation studies on human amylin fail to detect low-molecular-weight oligomers. Biophys J (2008) 1.00
Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer's disease. J Neuroinflammation (2012) 0.98
β-Amyloid oligomers in aging and Alzheimer's disease. Front Aging Neurosci (2013) 0.98
Free energy landscapes for amyloidogenic tetrapeptides dimerization. Biophys J (2005) 0.97
Deciphering the structure, growth and assembly of amyloid-like fibrils using high-speed atomic force microscopy. PLoS One (2010) 0.97
Effect of surfaces on amyloid fibril formation. PLoS One (2011) 0.97
Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation. Biochem J (1999) 0.97
Impact of the mutation A21G (Flemish variant) on Alzheimer's beta-amyloid dimers by molecular dynamics simulations. Biophys J (2006) 0.96
NSAID-based γ-secretase modulators do not bind to the amyloid-β polypeptide. Biochemistry (2011) 0.96
Intrinsic linear heterogeneity of amyloid β protein fibrils revealed by higher resolution mass-per-length determinations. J Biol Chem (2010) 0.96
A monoclonal antibody against synthetic Aβ dimer assemblies neutralizes brain-derived synaptic plasticity-disrupting Aβ. J Neurochem (2011) 0.95
A central role for dityrosine crosslinking of Amyloid-β in Alzheimer's disease. Acta Neuropathol Commun (2013) 0.94
Bapineuzumab alters aβ composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapy. PLoS One (2013) 0.94
P2Y2 nucleotide receptor-mediated responses in brain cells. Mol Neurobiol (2010) 0.94
Endocytic pathways mediating oligomeric Abeta42 neurotoxicity. Mol Neurodegener (2010) 0.92
In vitro Pb exposure disturbs the balance between Aβ production and elimination: the role of AβPP and neprilysin. Neurotoxicology (2011) 0.92
Antibody responses, amyloid-beta peptide remnants and clinical effects of AN-1792 immunization in patients with AD in an interrupted trial. CNS Neurol Disord Drug Targets (2009) 0.92
Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease. Am J Pathol (2008) 0.92
Lipid-induced beta-amyloid peptide assemblage fragmentation. Biophys J (2006) 0.91
Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner. Clin Exp Immunol (1999) 0.91
Amyloid-β oligomers stimulate microglia through a tyrosine kinase dependent mechanism. Neurobiol Aging (2011) 0.91
Pharmacotherapeutic targets in Alzheimer's disease. J Cell Mol Med (2008) 0.91
Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment. Biochem J (2002) 0.90
Ab initio modelling of the structure and redox behaviour of copper(I) bound to a His-His model peptide: relevance to the beta-amyloid peptide of Alzheimer's disease. J Biol Inorg Chem (2006) 0.89
Polymorphic structures of Alzheimer's β-amyloid globulomers. PLoS One (2011) 0.89
Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease. Front Cell Neurosci (2015) 0.89
The keystone of Alzheimer pathogenesis might be sought in Aβ physiology. Neuroscience (2015) 0.89
The molecular assembly of amyloid aβ controls its neurotoxicity and binding to cellular proteins. PLoS One (2011) 0.88
Preparation of fluorescently-labeled amyloid-beta peptide assemblies: the effect of fluorophore conjugation on structure and function. J Mol Recognit (2009) 0.88
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics. Alzheimers Res Ther (2014) 0.86
The amyloid beta ion channel hypothesis of Alzheimer's disease. Neuropsychiatr Dis Treat (2007) 0.86
The biochemical aftermath of anti-amyloid immunotherapy. Mol Neurodegener (2010) 0.86
Mechanism of accelerated assembly of beta-amyloid filaments into fibrils by KLVFFK(6). Biophys J (2004) 0.84
Role of aromatic side chains in amyloid β-protein aggregation. ACS Chem Neurosci (2012) 0.84
Amyloid β-peptide 1-42 modulates the proliferation of mouse neural stem cells: upregulation of fucosyltransferase IX and notch signaling. Mol Neurobiol (2014) 0.84
Structural Insight into an Alzheimer's Brain-Derived Spherical Assembly of Amyloid β by Solid-State NMR. J Am Chem Soc (2015) 0.84
Advances on the understanding of the origins of synaptic pathology in AD. Curr Genomics (2007) 0.83
Presenilin-1 280Glu-->Ala mutation alters C-terminal APP processing yielding longer abeta peptides: implications for Alzheimer's disease. Mol Med (2008) 0.82
Comparative studies on peptides representing the so-called tachykinin-like region of the Alzheimer Abeta peptide [Abeta(25-35)]. Biochem J (1998) 0.82
X-ray Crystallographic Structures of a Trimer, Dodecamer, and Annular Pore Formed by an Aβ17-36 β-Hairpin. J Am Chem Soc (2016) 0.82
The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders. Mol Psychiatry (2014) 0.81
Effects of amyloid β-peptides and gangliosides on mouse neural stem cells. Neurochem Res (2013) 0.81
Probing the efficacy of peptide-based inhibitors against acid- and zinc-promoted oligomerization of amyloid-β peptide via single-oligomer spectroscopy. Biophys Chem (2011) 0.80
The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy. Curr Neuropharmacol (2006) 0.80
Characterization of a Novel Mouse Model of Alzheimer's Disease--Amyloid Pathology and Unique β-Amyloid Oligomer Profile. PLoS One (2015) 0.80
In vivo Differential Brain Clearance and Catabolism of Monomeric and Oligomeric Alzheimer's Aβ protein. Front Aging Neurosci (2016) 0.80
Isolevuglandin adducts in disease. Antioxid Redox Signal (2015) 0.79
Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo. Am J Pathol (1999) 0.78
Ab initio model studies of copper binding to peptides containing a His-His sequence: relevance to the beta-amyloid peptide of Alzheimer's disease. J Biol Inorg Chem (2005) 0.78
High-resolution conformation and backbone dynamics of a soluble aggregate of apomyoglobin119. Biophys J (2011) 0.78
Amyloid β peptide-induced inhibition of endothelial nitric oxide production involves oxidative stress-mediated constitutive eNOS/HSP90 interaction and disruption of agonist-mediated Akt activation. J Neuroinflammation (2015) 0.77
Therapeutic interventions targeting Beta amyloid pathogenesis in an aging dog model. Curr Neuropharmacol (2011) 0.76
APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease. J Neurosci (2016) 0.76
Structural differences of amyloid-β fibrils revealed by antibodies from phage display. BMC Biotechnol (2015) 0.76
Proteomic analysis of the amyloid precursor protein fragment C99: expression in yeast. Anal Biochem (2007) 0.75
Orientation of tyrosine side chain in neurotoxic Aβ differs in two different secondary structures of the peptide. R Soc Open Sci (2016) 0.75
Tranilast binds to aβ monomers and promotes aβ fibrillation. Biochemistry (2013) 0.75
Anti-aβ oligomer IgG and surface sialic acid in intravenous immunoglobulin: measurement and correlation with clinical outcomes in Alzheimer's disease treatment. PLoS One (2015) 0.75
Numerical Simulations Reveal Randomness of Cu(II) Induced Aβ Peptide Dimerization under Conditions Present in Glutamatergic Synapses. PLoS One (2017) 0.75
Ganglioside-Dependent Neural Stem Cell Proliferation in Alzheimer's Disease Model Mice. ASN Neuro (2015) 0.75
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A (1998) 16.04
Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol (1999) 7.16
Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci (2001) 4.92
Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. Science (1990) 4.01
Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem (1996) 3.84
Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem (1993) 3.52
Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet (1999) 3.30
Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiol Aging (2004) 3.13
Tail-biting and tail-docking in pigs. Vet Rec (1998) 3.05
An inner membrane enzyme in Salmonella and Escherichia coli that transfers 4-amino-4-deoxy-L-arabinose to lipid A: induction on polymyxin-resistant mutants and role of a novel lipid-linked donor. J Biol Chem (2001) 2.95
beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc Natl Acad Sci U S A (1993) 2.80
Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science (1998) 2.76
Lipid A modifications characteristic of Salmonella typhimurium are induced by NH4VO3 in Escherichia coli K12. Detection of 4-amino-4-deoxy-L-arabinose, phosphoethanolamine and palmitate. J Biol Chem (1999) 2.56
A herpesvirus maturational proteinase, assemblin: identification of its gene, putative active site domain, and cleavage site. Proc Natl Acad Sci U S A (1991) 2.50
Hedgehog patterning activity: role of a lipophilic modification mediated by the carboxy-terminal autoprocessing domain. Cell (1996) 2.39
Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress. Exp Neurol (1995) 2.33
Lipid A modifications in polymyxin-resistant Salmonella typhimurium: PMRA-dependent 4-amino-4-deoxy-L-arabinose, and phosphoethanolamine incorporation. J Biol Chem (2001) 2.30
A strategy for rapid and efficient DNA sequencing by mass spectrometry. Nat Biotechnol (1996) 2.30
The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc Natl Acad Sci U S A (1996) 2.24
Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies. J Neurochem (2001) 2.14
Probenecid and zidovudine metabolism. Lancet (1989) 1.99
Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys J (1994) 1.99
Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol (1998) 1.92
Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell (1994) 1.92
Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J Exp Med (2000) 1.87
Oxygen requirement for the biosynthesis of the S-2-hydroxymyristate moiety in Salmonella typhimurium lipid A. Function of LpxO, A new Fe2+/alpha-ketoglutarate-dependent dioxygenase homologue. J Biol Chem (2000) 1.76
Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. Biochem Biophys Res Commun (1998) 1.72
The pallid gene encodes a novel, syntaxin 13-interacting protein involved in platelet storage pool deficiency. Nat Genet (1999) 1.62
Accumulation of a polyisoprene-linked amino sugar in polymyxin-resistant Salmonella typhimurium and Escherichia coli: structural characterization and transfer to lipid A in the periplasm. J Biol Chem (2001) 1.60
Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J Neurosci (1996) 1.59
Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma. Biochem Biophys Res Commun (2000) 1.57
Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J Biol Chem (1994) 1.56
Differential regulation of alternatively spliced endothelial cell myosin light chain kinase isoforms by p60(Src). J Biol Chem (2000) 1.56
The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy. J Protein Chem (1996) 1.56
Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens. Nat Med (2000) 1.51
Matrix-assisted laser desorption/ionization mass spectrometry of immobilized duplex DNA probes. Nucleic Acids Res (1995) 1.48
The 45-kilodalton protein of cytomegalovirus (Colburn) B-capsids is an amino-terminal extension form of the assembly protein. J Virol (1991) 1.46
Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations. Ann N Y Acad Sci (2000) 1.46
Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Brain Res Mol Brain Res (1991) 1.44
An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors. Curr Pharm Des (2008) 1.43
Tail-biting and tail-docking in pigs. Vet Rec (1998) 1.42
Purification and mass spectrometry of six lipid A species from the bacterial endosymbiont Rhizobium etli. Demonstration of a conserved distal unit and a variable proximal portion. J Biol Chem (2000) 1.40
p300/CBP-associated factor histone acetyltransferase processing of a peptide substrate. Kinetic analysis of the catalytic mechanism. J Biol Chem (2000) 1.38
Molecular modeling of the Abeta1-42 peptide from Alzheimer's disease. Protein Eng (1998) 1.37
Dimerization of the tat protein from human immunodeficiency virus: a cysteine-rich peptide mimics the normal metal-linked dimer interface. Proc Natl Acad Sci U S A (1988) 1.37
Dynamic O-GlcNAcylation of the small heat shock protein alpha B-crystallin. Biochemistry (1996) 1.37
Location of fatty acids in lipid A obtained from lipopolysaccharide of Rhodopseudomonas sphaeroides ATCC 17023. J Biol Chem (1988) 1.36
Ca2+-induced phosphoethanolamine transfer to the outer 3-deoxy-D-manno-octulosonic acid moiety of Escherichia coli lipopolysaccharide. A novel membrane enzyme dependent upon phosphatidylethanolamine. J Biol Chem (2001) 1.33
Hydrocarbon rulers in UDP-N-acetylglucosamine acyltransferases. J Biol Chem (1998) 1.29
Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosphorylation in response to Alzheimer's A beta peptide. J Biol Chem (1994) 1.26
Secretion of the beta/A4 amyloid precursor protein. Identification of a cleavage site in cultured mammalian cells. J Biol Chem (1991) 1.26
Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res (1998) 1.25
Amyloid-beta induces chemokine secretion and monocyte migration across a human blood--brain barrier model. Mol Med (1998) 1.25
Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits. Biochem Biophys Res Commun (1997) 1.24
High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease. Biochem Biophys Res Commun (1999) 1.23
Gas exchange characteristics of the sorghum-striga host-parasite association. Plant Physiol (1987) 1.22
Glycosylation of mammalian neurofilaments. Localization of multiple O-linked N-acetylglucosamine moieties on neurofilament polypeptides L and M. J Biol Chem (1993) 1.21
LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. J Pharmacol Exp Ther (1998) 1.20
Complement activation by neurofibrillary tangles in Alzheimer's disease. Neurosci Lett (2001) 1.20
The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease. J Biol Chem (1998) 1.18
Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem Int (1995) 1.18
Shortened hydroxyacyl chains on lipid A of Escherichia coli cells expressing a foreign UDP-N-acetylglucosamine O-acyltransferase. J Biol Chem (1997) 1.18
Cross-linking and binding of fibronectin with asymmetric acetylcholinesterase. Biochemistry (1981) 1.16
Compulsive exercise acutely upregulates rat hippocampal brain-derived neurotrophic factor. J Neural Transm (Vienna) (2005) 1.16
Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's disease. Biochim Biophys Acta (1998) 1.14
Apramycin, a unique aminocyclitol antibiotic. J Org Chem (1976) 1.14
RecA protein of Escherichia coli and chromosome partitioning. Mol Microbiol (1992) 1.14
Profiling of bacteria by fast atom bombardment mass spectrometry. Anal Chem (1987) 1.13
A mono-functional 3-deoxy-D-manno-octulosonic acid (Kdo) transferase and a Kdo kinase in extracts of Haemophilus influenzae. J Biol Chem (1997) 1.13
Dominance of a single peptide bound to the class I(B) molecule, Qa-1b. J Immunol (1997) 1.12
Chemical reduction of 3-oxo and unsaturated groups in fatty acids of diphosphoryl lipid A from the lipopolysaccharide of Rhodopseudomonas sphaeroides. Comparison of biological properties before and after reduction. J Biol Chem (1991) 1.11
Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (1996) 1.11
Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A. Biochem Biophys Res Commun (1994) 1.11
Synthesis of syn and anti isomers of 6-[[(hydroxyimino)phenyl]methyl]-1-[(1-methylethyl)sulfonyl]-1H-benzimidazol-2-amine. Inhibitors of rhinovirus multiplication. J Med Chem (1980) 1.11
A Haemophilus influenzae gene that encodes a membrane bound 3-deoxy-D-manno-octulosonic acid (Kdo) kinase. Possible involvement of kdo phosphorylation in bacterial virulence. J Biol Chem (1999) 1.10
Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism. Am J Pathol (2000) 1.09
Plasma desorption mass spectrometry: coming of age. Anal Chem (1988) 1.08
Matrix implanted laser desorption ionization (MILDI) combined with ion mobility-mass spectrometry for bio-surface analysis. J Proteome Res (2005) 1.07
Rapid impact of beta-amyloid on paxillin in a neural cell line. J Neurosci Res (1997) 1.07
Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluid. J Neurochem (1998) 1.06